In Treatment of Severe Depression with Anxiety Problem
In adolescent with event induced severe depression and anxiety
Significant reduction in PAR Scale & CGI Scale
72.9% remission at week 8 (MADRS < =10)
Treatment and maintenance for 3 months shows significant reduction in relapse
“In elderly patients with comorbid MDD and GAD, treatment with escitalopram 10 to 20 mg/d for 12 weeks was associated with significant improvements in symptoms of depression and anxiety”
May be used safely in Pregnant women as well as Lactating mothers
